Recruiting PHASE1 INTERVENTIONAL 2-arm NCT06813118

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

A RCT Comparing the Effectiveness of a Combination Therapy of Lezra and Clomid Versus Lezra Alone for Inducing Ovulation in Women Diagnosed With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome

Sponsor: HITEC-Institute of Medical Sciences

Conditions Polycystic Ovarian Syndrome

Interventions Clomiphene Citrate and letrozole

Updated 2 times since 2025 Last updated: Feb 3, 2025 Started: Jun 7, 2024 Primary completion: Feb 28, 2025 Completion: Mar 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Polycystic Ovarian Syndrome, this trial is actively recruiting participants. The trial is conducted by HITEC-Institute of Medical Sciences and has accumulated 2 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

2 versions recorded

Jun 2025 — Present [monthly]

Recruiting PHASE1
Mar 2025 — Jun 2025 [monthly]

Recruiting PHASE1

First recorded

Jun 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HITEC-Institute of Medical Sciences

Data source: HITEC-Institute of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rawalpindi, Pakistan